Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of four medications used in the treatment of inflammatory bowel diseases, particularly severe or complicated cases of Crohn's disease or ulcerative colitis. The combination includes:\n\n- **Azathioprine**: An immunosuppressant that reduces inflammation by suppressing the immune system\n- **Prednisone**: A corticosteroid that reduces inflammation\n- **Ustekinumab**: A monoclonal antibody that targets specific inflammatory pathways\n- **Vancomycin**: A glycopeptide antibiotic used to treat bacterial infections, particularly Clostridioides difficile infections that can complicate inflammatory bowel disease
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on azathioprine + prednisone + ustekinumab + vancomycin.